You are looking at 11 - 13 of 13 items for :

  • Kidney Health Initiative x
  • Refine by Content Type: All x
Clear All Modify Search
Zach Cahill

While dialysis is a life-saving therapy for patients with end stage kidney disease (ESKD), a variety of symptoms occur following treatment that significantly diminishes the quality of life of people living with kidney disease. A 2009 study published in the Clinical Journal of the American Society of Nephrology (CJASN) reported that patients on maintenance dialysis experience 11 unique symptoms. Patients have identified the need to alleviate these symptoms as a key research area, prioritizing it above other health outcomes. Alleviation of these symptoms could result in increased quality of life and better patient-reported outcome measures. Despite the patient demand for new therapies to address these symptoms, no drug or device has been approved by the US Food and Drug Administration (FDA) to date.

Zach Cahill

ttp _thumb_0.pngThe American Society Nephrology (ASN) is pleased to announce that Raymond C. Harris, MD, FASN , has been selected as the incoming ASN Co-Chair for the Kidney Health Initiative (KHI). Dr. Harris will serve a three-year term, starting in January 2019.  Dr. Harris will succeed Prabir Roy-Chaudhury, MD, PhD, FASN, who has served six years as KHI’s founding co-chair.

Ryan Murray and Zach Cahill

KidneyX_logo_0.PNGThe Kidney Health Initiative (KHI) and KidneyX are leading the fight to put new tools in the hands of kidney health professionals by stimulating the development of new solutions for patients with kidney diseases. Both of these initiatives help the kidney community by giving new tools to nephrologists in their fight against kidney diseases, providing inspiration to future nephrologists, and offering hope the patients we treat every day.